SeaStar Medical Holding Corp (ICU)
4.28
+0.22
(+5.42%)
USD |
NASDAQ |
Sep 27, 16:00
4.24
-0.04
(-0.93%)
After-Hours: 20:00
SeaStar Medical Research and Development Expense (TTM): 6.213M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.213M |
| March 31, 2024 | 5.86M |
| December 31, 2023 | 5.893M |
| September 30, 2023 | 5.643M |
| June 30, 2023 | 5.263M |
| Date | Value |
|---|---|
| March 31, 2023 | 3.878M |
| December 31, 2022 | 2.503M |
| September 30, 2022 | 2.214M |
| June 30, 2022 | 2.233M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
2.214M
Minimum
Sep 2022
6.213M
Maximum
Jun 2024
4.411M
Average
5.263M
Median
Jun 2023
Research and Development Expense (TTM) Benchmarks
| Bolt Biotherapeutics Inc | 63.24M |
| CVS Health Corp | -- |
| Walgreens Boots Alliance Inc | -- |
| Nuwellis Inc | 4.381M |
| Verastem Inc | 72.22M |